$NKE

Barclays Sees $45 and Wolfe Sees $28 for Nike Stock. Here’s Where the Stock Could Go

Barclays raised its price target on Nike to $45, while Wolfe Research initiated coverage with a $28 target. Nike's stock closed at $38.32, above the Street's average target of $36.50. Barclays' upgrade was based on a higher valuation multiple, not improved earnings estimates. Analysts expect Nike's revenue to decline in fiscal 2027 but grow slightly in fiscal 2028. Nike's management cited weak lifestyle demand as a key challenge.

Original reporting
Published Oct 23, 2026, 9:19 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 23, 2026, 9:52 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Barclays Sees $45 and Wolfe Sees $28 for Nike Stock. Here’s Where the Stock Could Go — source image
Decision brief

The 30-second read

$NKENeutralMed
01

Why it matters

Analyst target changes provide fresh data points for traders to gauge short-term price direction.

02

Market read

New analyst targets introduce fresh valuation perspectives for Nike, influencing trader sentiment.

03

What to watch

Potential upcoming product launches and international demand may offset short-term earnings concerns.

Relevance 7/10Novelty 7/10Timing: pre-market today

Background

Nike's recent earnings guidance showed modest revenue declines, prompting analyst target revisions.

Company-level read

Ticker impact

$NKENeutralMedium confidence
Context

Barclays raised its price target on Nike to $45 and Wolfe Research set a $28 target, showing divergent analyst views.

Expected impact

potential pressure as lower target is priced in, with upside support from higher Barclays target

Evidence & confidence

Divergent targets reflect uncertainty; traders may watch for price reaction to the new guidance.

Market effects

Sportswear sector may see heightened scrutiny as analysts reassess growth outlook.

U.S. consumer discretionary stocks could experience modest ripple effects.

Limited to Nike and its peers; no broad market impact.

Counterpoint

Despite lower Wolfe target, Nike's brand strength could sustain price above current levels.

Key entities

  • Barclays

    Raised Nike price target to $45.

  • Wolfe Research

    Set Nike price target at $28.

Related articles

$LULUMed

Athletic Apparel Stocks Fall as Retail Selling Spreads: Lululemon and Under Armour Drop 4%, Nike Retreats 2%

Lululemon (LULU) and Under Armour (UAA) shares fell 4% each, while Nike (NKE) dropped 2% amid a broader retail selloff. Lululemon reported Q2 FY2026 revenue of $2.42B, down 4.3% YoY, and lowered full-year guidance. The SPDR S&P Retail ETF (XRT) declined 2%, less than the athletic apparel sector. U.S. retail sales rose 0.8% in September, contrasting with the selloff driven by sentiment toward premium apparel.

$NKEMed

Nike’s After Dark Tour returns to what made the brand special

Nike hosted its After Dark Tour 10K for 5,000 women in London, aiming to empower female runners. The event follows Nike's revenue decline and restructuring. Seema Simmons, Nike's VP of North America running, led the initiative. Nike reported a 4% revenue decline to $11.2B for fiscal Q1 2027 and forecasts further drops. The company's shares fell to a 13-year low. The event seeks to reconnect with women runners, addressing safety concerns highlighted by a 2024 Adidas survey.

HighAI 8/10

Adidas’ record Q3 is salt in the wound for Nike

Adidas reported record Q3 revenue of 7.3 billion euros, up 9% YoY, and raised full-year profit guidance to 2.5 billion euros. CEO Gulden credited marketing and innovation for growth. Analysts note 11 quarters of strong growth, with market share gains over Nike, which saw Q3 revenue decline 4% YoY.

High

Adidas accelerates and widens its lead over Nike

Adidas raised its FY earnings forecast after Q3 operating income rose 37% to €1.008bn, driven by sales growth and a €300m US tariff reimbursement. Analysts noted the outperformance and raised estimates. Nike, meanwhile, is working to correct strategic mistakes and regain growth, particularly in China. Adidas shares have outperformed Nike's over the past year.